Product Details for: Danyelza

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
40MG/10ML (4MG/ML)
Single-Dose Vial
351(a)
Danyelza
Rx
Proper Name
naxitamab-gqgk
BLA Number
761171
Applicant
Y-mABs Therapeutics, Inc
Original Approval Date
November 25, 2020
Date of First Licensure
RETURN TO SEARCH RESULTS